Susceptibility gene for familial acute myeloid leukemia associated with loss of 5q and/or 7q is not localized on the commonly deleted portion of 5q

Genes Chromosomes and Cancer

Volumn 28, Issue 2, 2000, Pages 164-172

  Gao, Qing ^a   Horwitz, Marshall ^b   Roulston, Diane ^a   Hagos, Fitsum ^a   Zhao, Nanding ^a   Freireich, Emil J ^c   Golomb, Harvey M ^a   Olopade, Olufunmilayo I ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE MYELOBLASTIC LEUKEMIA; ARTICLE; CANCER SUSCEPTIBILITY; CHROMOSOME 5Q; CHROMOSOME 7Q; CLINICAL ARTICLE; FAMILY STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; HETEROZYGOSITY LOSS; HUMAN; MALE; PEDIGREE; PRIORITY JOURNAL;

EID: 0034015768     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(200006)28:2<164::AID-GCC5>3.0.CO;2-2     Document Type: Article

References (40)

1. Arthur DC, Bloomfield CD. 1983. Partial deletion of the lung arm of chromosome 16 and bone marrow eosinophilia in acute nonlymphocytic leukemia: a new association. Blood 61:9994-9998.
2. Betts DR, Rohatiner AZ, Evans ML, Rassam SM, Lister TA, Gibbons B. 1992. Abnormalities of chromosome 16q in myeloid malignancy: 14 new cases and a review of the literature. Leukemia 6:1250-1256.
3. Boehnke M, Lange K, Cox DR. 1991. Statistical methods for multipoint radiation hybrid mapping. Am J Hum Genet 49:1174-1188.
4. Busque L, Gilliland G. 1993. Clonal evolution in acute myeloid leukemia. Blood 82:337-342.
5. Calasanz MJ, Cigudosa JC, Odero MD, Ferreira C, Ardanaz MT, Fraile A, Carrasco JL, Sole F, Cuesta B, Gullon A. 1997. Cytogenetic analysis of 280 patients with multiple myeloma and related disorders: primary breakpoints and clinical correlations. Genes Chromosomes Cancer 18:84-93.
6. Collins A, Frezal J, Teague J, Morton NE. 1996. A metric map of humans: 23,500 loci in 850 bands. Proc Natl Acad Sci USA 93: 14771-14775.
7. De Lord C, Powles R, Mehta J, Wilson K, Treleaven J, Meller S, Catovsky D. 1998. Familial acute myeloid leukemia: four male members of a single family over three consecutive generations exhibiting anticipation. Br J haematol 100:557-560.
8. Dutrillaux B, Gerbault-Seureau M, Zafrani B. 1990. Characterization of chromosomal anomalies in human breast cancer: a comparison of 30 paradiploid cases with few chromosome changes. Cancer Genet Cytogenet 49:203-217.
9. Fasman KH, Letovsky SI, Cottingham RW, Kinsbury DT. 1996. Improvements to the GDB human genome data base. Nucl Acids Res 24:57-63.
10. Ferro MT, Garcia-Sagredo JM, Resino M, del Potro E, Villegas A, Mediavilla J, Espinos D, San Roman C. 1984. Chromosomal disorder and neoplastic diseases in a family with inherited fragile 16: causality or casualty? Cancer Genet Cytogenet 78:160-164.
11. Filippova GN, Lindblom A, Meincke LJ, Klenova EM, Neiman PE, Collins SJ, Doggett NA, Lobanenkov VV. 1998. A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers. Genes Chromosomes Cancer 22:26-36.
12. Francastel C, Poindessous-Jazat V, Augery-Bourget Y, Robert-Lezenes J. 1997. NF-E2p18/mafK is required in DMSO-induced differentiation of Friend erythroleukemia cells by enhancing NF-E2 activity. Leukemia 11:273-280.
13. Ho CY, Otterud B, Legare RD, Varvil T, Saxena R, DeHart DB, Kohler SE, Aster JC, Dowton SB, Li FP, Leppert M, Gilliland DG. 1996. Linkage of a familial platelet disorder with a propensity to develop myeloid malignancies to human chromosome 21q22.1-22.2. Blood 87:5218-5224.
14. Horwitz M. 1997. The genetics of familial leukemia. Leukemia 11:1347-1359.
15. Horwitz M, Sabath DE, Smithson WA, Radich J. 1996. A family inheriting different subtypes of acute myelogenous leukemia. Am J Hematol 52:295-304.
16. Horwitz M, Benson KF, Li F-Q, Wolff J, Leppert MF, Hobson L, Mangelsdorf M, Yu S, Hewett D, Richards RI, Raskind WH, 1997. Genetic heterogeneity in familial acute myelogenous leukemia: evidence for a second locus at chromosome 16q21-23.2. Am J Hum Genet 61:873-881.
17. Iida A, Isobe R, Yoshimoto M, Kasumi F, Nakamura Y, Emi M. 1997. Localization of a breast cancer tumour-suppressor gene to a 3-cM interval within chromosomal region 16q22. Br J Cancer 75:264-267.
18. Igarashi K, Itoh K, Hayashi N, Nishizawa M, Yamamoto M. 1995. Conditional expression of the ubiquitous transcription factor MafK induces erythroleukemia cell differentiation. Proc Natl Acad Sci USA 92:7445-7449.
19. Innis MA, Gelfand D, Sninsky JJ, White TJ. 1990. PCR Protocols. San Diego: Academic Press.
20. Johansson B, Mertens F, Mitelman F. 1993. Cytogenetic deletion maps of hematologic neoplasms: circumstantial evidence for tumor suppressor loci. Genes Chromosomes Cancer 8:205-218.
21. Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES. 1996. Parametric and nonparamctric linkage analysis: a unified multipoint approach. Am J Hum Genet 58:1347-1363.
22. Lathrop GM, Lalouel JM, Julier C, Ott J. 1984. Strategies for multilocus linkage analysis in humans. Proc Natl Acad Sci USA 81:3443-3446.
23. Le Beau MM, Rowley JD. 1984. Heritable fragile site in cancer Nature 308:607-608.
24. Lewis S, Oscier D, Boultwood J, Ross F, Fitchett M, Rack K, Abrahamson G, Buckle V, Wainscoat JS. 1995. Hematological features of patients with myelodysplastic syndromes associated with a chromosome 5q deletion. Am J Hematol 49:194-200.
25. Liu PP, Hajra A, Wijmenga C, Collins FS. 1995. Molecular pathogenesis of the chromosome 16 inversion in the M4Eo subtype of acute myeloid leukemia. Blood 86:2289-2302.
26. Maw MA, Grundy PE, Millow LJ, Eccles MR, Dunn RS, Smith PJ, Feinberg AP, Law DJ, Paterson MC, Telzerow PE, et al. 1992. A third Wilms' tumor locus on chromosome 16q. Cancer Res 52: 3094-3098.
27. Marlton P, Keating M, Kantarjian H, Pierce S, O'Brien S, Freireich EJ, Estey E. 1995. Cytogenetic and clinical correlates in AML patients with abnormalities of chromosome 16. Leukemia 9:965-971.
28. Ohyashiki K, Ohyashiki JH, Iwabuchi A, Ito H, Toyama K. 1988. Central nervous system involvement in acute nonlymphocytic leukemia with inv(16)(p13q22). Leukemia 2:398-399.
29. Olopade OI, Roulston D, Baker T, Narvid S, Le Beau MM, Freireich EJ, Larson RA, Golomb HM. 1996. Familial myeloid leukemia associated with loss of the long arm of chromosome 5. Leukemia 10:669-674.
30. Ott J. 1989. Computer-simulation methods in human linkage analysis. Proc Natl Acad Sci USA 86:4175-4178.
31. Rabbitts TH. 1994. Chromosomal translocations in human cancer. Nature 372:143-149.
32. Rowley JD. 1976. The role of cytogenetics in hematology. Blood 48:1-7.
33. Sato T, Saito H, Morita R, Koi S, Lee JH, Nakamura Y. 1991. Allelotype of human ovarian cancer. Cancer Res 51:5118-5122.
34. Shannon KM, Turhan AG, Rogers PCJ, Kan YW. 1995. Evidence implicating heterozygous deletion of chromosome 7 in the pathogenesis of familial leukemia associated with monsomy 7. Genomics 14:121-125.
35. Song WJ, Sullivan M, Legare RD, Hutchins S, Tan X, Kufrin D, Ratajczak J, Resende IC, Haworth C, Hock R, Loh M, Felix C, Roy DC, Busque L, Kurnit D, Willman C, Gewirtz AM, Speck NA, Busweller JH, Li F, Gardiner K, Poncz M, Maris JM, DG Gilliland. 1999. Haploinsufficiency of CBFA2 causes familial thromhocytopenia with propensity to develop acute myelogenous leukemia. Nat Genet 23:166-174.
36. Szubryt SR, Neuman WL, Westbrook CA. 1993. Dinucleotide repeat polymorphism at the D5S17H locus. Hum Mol Genet 2:90.
37. van Den Berghe H, Cassiman JJ, David G, Fryns JP, Michaux JL, Sokal G. 1974. Distinct hematological disorder with deletion of the long arm of no. 5 chromosome. Nature 251:437-438.
38. Weeks DE, Ott J, Lathrop GM. 1990. SLINK: a general simulation program for linkage analysis. Am J Hum Genet 47:A204.
39. Zeleznik-Le NJ, Nucifora G, Rowley JD. 1995. The molecular biology of myeloproliferative disorders as revealed by chromosomal abnormalities. Semin Hematol 32:201-219.
40. Zhao N, Stoffel A, Wang PW, Eisenbart JD, Espinosa R 3rd, Larson RA, Le Beau MM. 1997. Molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases to 1-1.5 Mb and preparation of a PAC-based physical map. Proc Natl Acad Sci USA 94:6948-6953.